CD79A and common variable immunodeficiency: BC has been observed in 42–73% of common variable immunodeficiency (CVID) patients, affected by a marked reduction of IgG, IgA, and/or IgM [57], and in whom immunoglobulin replacement is an important tool to avoid the progression of BC [58].